Cargando…

Incidence of atrial fibrillation in patients with central retinal artery occlusion: A Systematic Review and Meta-Analysis

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Central retinal artery occlusion (CRAO) is a devastating event and atrial fibrillation (AF) is a recognized cause that may not be present at the time of the event. PURPOSE: We performed a meta-analysis for the association of CRAO w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nedios, S, Prakash, G, Anjos, R, Miguel, A, Salangsang, J, Hindricks, G, Bollmann, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	10.2.2 - Stroke in Atrial Fibrillation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207135/ http://dx.doi.org/10.1093/europace/euad122.042

Ejemplares similares

Electrophysiological findings in patients undergoing left atrial appendage occlusion following previous electrical isolation
por: Della Rocca, D, et al.
Publicado: (2023)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
por: Lee, S R, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

Effect of history of atrial arrhythmias on the rate of recurrent stroke in patients after PFO closure
por: Jiravsky, O, et al.
Publicado: (2023)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022)

Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Future Directions for Mapping Atrial Fibrillation
por: Zaman, Junaid AB, et al.
Publicado: (2022)

Pulsed Field Ablation for Atrial Fibrillation
por: Schaack, David, et al.
Publicado: (2023)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Rosa, Giulio La, et al.
Publicado: (2021)

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
por: Verberk, Willem J.
Publicado: (2022)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
por: Lee, Justin Z., et al.
Publicado: (2021)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
por: van Schie, Mathijs S, et al.
Publicado: (2022)

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
por: Coccina, Francesca, et al.
Publicado: (2020)

A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
por: Kaba, Riyaz A, et al.
Publicado: (2022)

Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
por: Matsumori, Akira
Publicado: (2022)

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study
por: Wang, Chang, et al.
Publicado: (2023)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China
por: Xia, Zhenwei, et al.
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements
por: Huang, Pin‐Hsiang, et al.
Publicado: (2022)

Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities for Neuromodulation for the Management of Atrial Fibrillation
por: Aksu, Tolga, et al.
Publicado: (2023)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Atrial fibrillation and in-hospital mortality in Covid-19 patients
por: Kotadia, I, et al.
Publicado: (2023)

How often atrial flutter and atrial fibrillation coexist? Results from a large nationwide ECG-based study
por: Aro, A, et al.
Publicado: (2023)

Baseline pr internal prolongation and elevated diastolic blood pressure are predictors of new-onset atrial fibrillation in hypertensive patients
por: Papakonstantinou, P, et al.
Publicado: (2023)

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
por: Choi, Y, et al.
Publicado: (2023)

Heart rate fragmentation as a marker of altered activity of the autonomic nervous system activity : a novel predictor of atrial fibrillation occurrence in the general population
por: Guichard, J B, et al.
Publicado: (2023)

Disagreement of ESC guidelines from 2016 and 2021 and HFA-PEFF and H2 FPEF scores in diagnosis of heart failure with preserved ejection fraction in atrial fibrillation patients
por: Gawalko, M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lun5qoh041hr7du4t6r0egs25a